Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases: a Phase I/II Study
Conditions
Interventions
genetically modified dendritic cells + cytokine-induced killer
Locations
1
China
Affiliated Hospital to Academy of Military Medical Sciences
Beijing, Beijing Municipality, China
Start Date
February 1, 2016
Primary Completion Date
February 1, 2018
Last Updated
February 23, 2016
Lead Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions